Log in
Enquire now

List of Fuso Pharmaceutical Industries,Ltd. patents

List of Fuso Pharmaceutical Industries,Ltd. patents
List of Secure Channels Inc. patents
List of TMGcore, LLC patents
List of SCIMEASURE ANALYTICAL SYSTEMS, INC. patents
List of SBIR/STTR awards granted to Capco, Llc
List of companies in Ahmet Bilgen's investment portfolio
Patents where
Current Assignee
Name
is
Fuso Pharmaceutical Industries,Ltd.Fuso Pharmaceutical Industries,Ltd.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7612175 Scavenger receptor

Patent 7612175 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on November, 2009 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7612175
November 3, 2009
‌
US Patent 7612174 Scavenger receptor

Patent 7612174 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on November, 2009 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7612174
November 3, 2009
‌
US Patent 7550437 Compositions for preventing and treating digestive organs diseases

Patent 7550437 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on June, 2009 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7550437
June 23, 2009
‌
US Patent 7351541 Method for diagnosing a renal disorder

Patent 7351541 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on April, 2008 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7351541
April 1, 2008
‌
US Patent 7029909 Protein expression vector and utilization thereof

Patent 7029909 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on April, 2006 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7029909
April 18, 2006
‌
US Patent 7358061 Methods of diagnosing thyroid carcinoma

Patent 7358061 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on April, 2008 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7358061
April 15, 2008
‌
US Patent 7348306 Composition for promoting lacrimal secretion

Patent 7348306 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on March, 2008 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7348306
March 25, 2008
‌
US Patent 11193162 Nucleic acid detection or quantification method using mask oligonucleotide, and device for same

Patent 11193162 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on December, 2021 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11193162
December 7, 2021
‌
US Patent 9029627 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor

Patent 9029627 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on May, 2015 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9029627
May 12, 2015
‌
US Patent 7985833 Collectin

Patent 7985833 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on July, 2011 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7985833
July 26, 2011
‌
US Patent 9540658 Adenovirus vector

Patent 9540658 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on January, 2017 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9540658
January 10, 2017
‌
US Patent 9840452 Sodium diacetate crystal and solid dialysis preparation comprising said crystal

Patent 9840452 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on December, 2017 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9840452
December 12, 2017
‌
US Patent 8187805 Method of detecting nucleic acid and utilization thereof

Patent 8187805 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on May, 2012 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8187805
May 29, 2012
‌
US Patent 9410120 Composition for embryo culture

Patent 9410120 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on August, 2016 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9410120
August 9, 2016
‌
US Patent 7723060 Method for diagnosing renal disorder, hemolytic uremic syndrome and enterohemorrhagic infectious disease caused by

Patent 7723060 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on May, 2010 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7723060
May 25, 2010
‌
US Patent 7723061 Method for diagnosing renal disorder, hemolytic uremic syndrome and enterohemorrhagic infectious disease caused by

Patent 7723061 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on May, 2010 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7723061
May 25, 2010
‌
US Patent 9700024 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor

Patent 9700024 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on July, 2017 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
9700024
July 11, 2017
‌
US Patent 8354500 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target

Patent 8354500 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on January, 2013 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8354500
January 15, 2013
‌
US Patent 7572890 Recombinant human mannan-building proteins

Patent 7572890 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on August, 2009 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7572890
August 11, 2009
‌
US Patent 8410253 Scavenger receptor

Patent 8410253 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on April, 2013 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8410253
April 2, 2013
‌
US Patent 8815598 Trophectodermal cell-specific gene transfer methods

Patent 8815598 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on August, 2014 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8815598
August 26, 2014
‌
US Patent 7651837 Method for detecting and identifying microorganism causative of infection

Patent 7651837 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on January, 2010 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7651837
January 26, 2010
‌
US Patent 8084578 Monoclonal antibody against human scavenger receptor SRCL-P1

Patent 8084578 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on December, 2011 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
8084578
December 27, 2011
‌
US Patent 7563594 Cytolethal distending toxins and detection of

Patent 7563594 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on July, 2009 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
7563594
July 21, 2009
‌
US Patent 11519893 Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases

Patent 11519893 was granted and assigned to Fuso Pharmaceutical Industries,Ltd. on December, 2022 by the United States Patent and Trademark Office.

Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
United States Patent and Trademark Office
United States Patent and Trademark Office
11519893
December 6, 2022
Results per page:
39 results
0 selected
39 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us